a month ago
PODD
AnalystsLee HambrightLee Hambright's Stock Forecasts
AnalystsLee Hambright
Analyst Ranking
Bottom 8%
#5073 out of 5510 analysts
Average Return
-2.99%
Win Rate
48%16 out of 33
Risk vs Reward
Poor
Good
Lee Hambright's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Dexcom IncDXCM | +73.52% | $79.14 | $137.32 | 2022-07-15 - 2023-07-14 | Buy |
Insulet CorpPODD | +31.40% | $239.30 | $314.44 | 2024-11-06 - 2025-11-05 | Buy |
Intuitive Surgical IncISRG | +31.04% | $307.84 | $403.39 | 2023-05-31 - 2024-05-30 | Buy |
Dexcom IncDXCM | +25.64% | $67.40 | $84.68 | 2026-01-09 - 2026-09-14 | Buy |
Edwards Lifesciences CorpEW | +24.63% | $21.67 | $27.00 | 2014-12-04 - 2015-12-04 | Buy |
Lee Hambright Analyst Color
Get additional color on Lee Hambright's coverage of popular stocks
2 months ago
ISRG
Lee Hambright's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zimmer Biomet Holdings IncZBH | 3 | Hold | $93.00 | -3.67% | Maintains | a month ago |
Insulet CorpPODD | 5 | Buy | $175.00 | +27.00% | Maintains | a month ago |
Intuitive Surgical IncISRG | 5 | Buy | $685.00 | +81.25% | Maintains | 2 months ago |
Medtronic PLCMDT | 5 | Buy | $97.00 | +3.41% | Maintains | 3 months ago |
Medline IncMDLN | 2 | Buy | $54.00 | +65.69% | Maintains | 4 months ago |
Abbott LaboratoriesABT | 7 | Buy | $125.00 | +21.25% | Maintains | 8 months ago |
Tandem Diabetes Care IncTNDM | 2 | Hold | $25.00 | +48.72% | Maintains | 8 months ago |
Stryker CorpSYK | 2 | Buy | $465.00 | +64.97% | Maintains | 8 months ago |
Johnson & JohnsonJNJ | 3 | Hold | $208.00 | -21.90% | Maintains | 8 months ago |
Dexcom IncDXCM | 3 | Buy | $86.00 | +1.56% | Maintains | 8 months ago |
Boston Scientific CorpBSX | 1 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Edwards Lifesciences CorpEW | 3 | Buy | $135.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.